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Abstract
Background: Haemosuccus pancreaticus (HP) is a rare cause of upper gastrointestinal bleeding. The
objective of our study was to highlight the challenges in the diagnosis and management of HP.
Methods: The records of 31 patients with HP diagnosed between January 1997 and June 2008 were
reviewed retrospectively.hpb_063 345..350
Results: Mean patient age was 34 years (11–55 years). Twelve patients had chronic alcoholic pancre-
atitis, 16 had tropical pancreatitis, two had acute pancreatitis and one had idiopathic pancreatitis.
Selective arterial embolization was attempted in 22 of 26 (84%) patients and was successful in 11 of the
22 (50%). Twenty of 31 (64%) patients required surgery to control bleeding after the failure of arterial
embolization in 11 and in an emergent setting in nine patients. Procedures included distal pancreatec-
tomy and splenectomy, central pancreatectomy, intracystic ligation of the blood vessel, and aneurysmal
ligation and bypass graft in 11, two, six and one patients, respectively. There were no deaths. Length of
follow-up ranged from 6 months to 10 years.
Conclusions: Upper gastrointestinal bleeding in a patient with a history of chronic pancreatitis could be
caused by HP. Diagnosis is based on investigations that should be performed in all patients, preferably
during a period of active bleeding. These include upper digestive endoscopy, contrast-enhanced com-
puted tomography (CECT) and selective arteriography of the coeliac trunk and superior mesenteric artery.
Contrast-enhanced CT had a high positive yield comparable with that of selective angiography in our
series. Therapeutic options consist of selective embolization and surgery. Endovascular treatment can
control unstable haemodynamics and can be sufficient in some cases. However, in patients with persis-
tent unstable haemodynamics, recurrent bleeding or failed embolization, surgery is required.
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Introduction
Haemosuccus pancreaticus (HP) is a rare cause of upper gas-
trointestinal (UGI) bleeding. This condition has been estimated
to occur in about one in 1500 cases of gastrointestinal (GI) tract
haemorrhage. Haemosuccus most commonly occurs in associa-
tion with chronic pancreatitis and the formation of pseudoan-
eurysms in peripancreatic vessels. It can also occur where
primary aneurysms rupture into the pancreatic duct or, more
rarely, persuant to ductal calculi, villous adenomatosis or arte-
riovenous malformations.1 The diagnosis is not always easy to
establish and often a long period elapses between the onset of
the first symptoms and the precise location of the source of
bleeding.
The objective of our study was to highlight the challenges
involved in the diagnosis and management of HP.
Materials and methods
The records of 31 patients with HP diagnosed between January
1997 and June 2008 were reviewed retrospectively. We noted
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demographic data, history, diagnostic features including symp-
toms, physical examination and time to diagnosis, investigations
and therapeutic modalities, as well as follow-up data.
Results
The sample included 26 men and five women. Mean age was 34
years (11–55 years). Twelve patients had chronic alcoholic pancre-
atitis, 16 had tropical pancreatitis, two had acute pancreatitis and
one had idiopathic pancreatitis. A total of 17 patients had a
pseudocyst (eight in the head, six in the body and three in the tail
of the pancreas). Presenting symptoms were haematemesis in 10,
malena in 31 and worsening of anaemia in 30 patients. Transfu-
sion requirements ranged from 3 units to 12 units (mean = 6
units).
Diagnosis
Upper GI endoscopy showed the presence of blood in the duode-
num in 16 of 31 (51%) patients. The remaining patients had
normal UGI endoscopic findings. Contrast-enhanced computed
tomography (CECT) was performed in all 31 patients and showed
a pseudoaneurysm in 28 (90%) patients (Figs 1A, 2A, 3A). Con-
ventional angiography was carried out in 26 patients (Fig. 1B).
The pseudoaneurysm arose from the splenic artery in 17 patients,
from the gastroduodenal artery in five, from a branch of the
superior pancreaticoduodenal artery in one, from the inferior
pancreaticoduodenal artery in two and from the superior mesen-
teric artery in one patient. An unnamed vessel in the pseudocyst
wall was the cause of bleed in four patients. A ductal communi-
cation with the splenic vein was found in one patient. Angiogra-
phy enabled aetiological diagnosis in 23 of 26 (88%) cases.
Abdominal ultrasonography with Doppler examination was per-
formed in all patients and diagnosed aneurysmal bleeding in 12
patients. An arterial abnormality was found to be the principle
cause in 30 of 31 (97%) patients. Thirteen pseudoaneurysms had
ruptured into the pancreatic duct directly and 17 patients had
bleeding into the pseudocyst (Table 1).
Management
Selective arterial embolization was attempted in 22 of 26 (84%)
patients and was successful in 11 of these 22 (50%). Twenty of 31
(64%) patients required surgery to control bleeding after the
failure of arterial embolization in 11 and in an emergent setting in
nine patients. Procedures included distal pancreatectomy and
splenectomy (Fig. 2B) in 11 cases, central pancreatectomy
(Fig. 1C) in two cases, intracystic ligation of the blood vessel
(Fig. 3B) in six cases and aneurysmal ligation and bypass graft in
one case (Table 2). There were no deaths. Morbidity included
external pancreatic fistula in two patients (both were managed
conservatively), wound infection in two, incisional hernia in one
and pneumonia in one patient.
Follow-up
Length of follow-up ranged from 6 months to 10 years. Three
patients were lost to follow-up, leaving 28 patients, none of whom
(A)
(B)
(C)
Figure 1 (A) Contrast-enhanced computed tomography showing a
pseudoaneurysm of the splenic artery. (B) Conventional angiography
showing a large splenic artery pseudoaneurysm. (C) Excised
pseudoaneurysm and central pancreatectomy specimen
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experienced recurrent bleeding. Three of the patients with chronic
pancreatitis who had undergone previous embolization developed
intractable pain and needed drainage procedures.
Discussion
The term ‘haemosuccus pancreaticus’ was first coined by Sand-
blom2 in 1970 to describe the syndrome of GI bleeding into the
pancreatic duct, manifested by bleeding through the ampulla of
Vater. The condition was first described in 1931 by Lower and
Farell,3 since when about 125 cases have been reported in the
literature.4,5
Haemosuccus pancreaticus is observed predominantly in men
(sex ratio: 7:1), especially in relation to chronic alcohol intake.
Mean age at onset is about 50 years when the pancreatic paren-
chyma is involved and about 60 years when the condition is of
purely arterial origin.6 Clinical symptoms and signs include UGI
bleeding as evidenced by haematemesis and malena, of which
malena is more common, and epigastric pain resulting from the
elevation of pressure in the pancreatic ducts caused by blood
clots.7,8 The haemorrhage is usually intermittent, repetitive and,
most often, not severe enough to cause haemodynamic instability
despite the usual arterial origin of bleeding.9 Other clinical signs
(A)
(B)
Figure 2 (A) Contrast-enhanced computed tomography showing a
splenic artery pseudoaneurysm against a background of chronic
calcific pancreatitis. (B) Distal pancreatectomy and splenectomy
specimen
(A)
(B)
Figure 3 Pseudoaneurysm in the head of the pancreas shown by (A)
contrast-enhanced computed tomography and (B) intraoperative
photography
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are more exceptional and include: jaundice by pancreaticobiliary
reflux secondary to clot formation;5,7 vomiting; weight loss, and a
palpable pulsating mass with a systolic thrill in the event of aneu-
rysm. Iron deficiency is frequent, but liver function test is normal
apart from increased serum bilirubin in the event of pancreatico-
biliary reflux. Serum amylase is normal outside episodes of acute
pancreatitis.8
In 80% of cases, HP complicates an underlying pancreatic
disease; 20% of cases correspond to a vascular anomaly.5 In our
series, as in others, chronic pancreatitis was the main cause.
Several mechanisms may be involved:5
1 the natural course of a pseudocyst may produce HP, either
because the pseudocyst is haemorrhagic or because it commu-
nicates with and erodes a pericystic artery10;
2 HP may result from vascular ulceration caused by an intraduc-
tal stone;
3 HP may result from vascular ulceration caused by a dilated and
cystic main pancreatic duct, and
4 arterial aneurysm and pseudoaneurysm,known to have a higher
frequency in chronic pancreatitis (10%), may develop.11,12
Aneurysm and chronic pancreatitis are often associated, but no
causal relationship has been clearly established. Other pancreatic
causes of HP are rare and include neuroendocrine tumour,5
ectopic pancreas13 and pancreas divisum.14 During an episode of
acute pancreatitis, HP can occur after necrosis of an arterial wall
(duodenopancreatic arcade, gastroduodenal artery, splenic
artery). Finally, HP can occur as a complication of endoscopic
retrograde cholangiopancreatography.
It is difficult to diagnose HP because the bleeding is usually
intermittent. An endoscopic examination of the UGI tract may
reveal the bleeding to be from the pancreatic duct. It can also be
normal and rule out other causes of upper digestive bleeding
(erosive gastritis, peptic ulcers, oesophageal and gastric fundus
varices). Ultrasonography can be used to visualize pancreatic
pseudocysts or aneurysm of the peripancreatic arteries. Doppler
ultrasound or dynamic ultrasound has been reported to be diag-
nostic.11,15 Contrast-enhanced CT is an excellent modality for
demonstrating the pancreatic pathology and can also demonstrate
features of chronic pancreatitis, pseudocysts and pseudoaneu-
rysms.16 On pre-contrast CT, the characteristic finding of clotted
blood in the pancreatic duct, known as the sentinel clot, is seldom
seen.17 Computed tomography may show simultaneous opacifica-
tion of an aneurysmal artery and pseudocyst or persistence of
contrast within a pseudocyst after the arterial phase. Again, these
findings are only suggestive of the diagnosis. In our series, CECT
was diagnostic in 28 of 31 (90%) cases.
Ultimately, angiography is the diagnostic reference standard.
Angiography identifies the causative artery and allows for delin-
eation of the arterial anatomy and therapeutic intervention.
Selective arteriography of the coeliac trunk and superior mesen-
teric artery provides formal proof of HP in the form of opaci-
fication of the main pancreatic duct (Fig. 4). It can also identify
the presence of an aneurysm or pseudoaneurysm. Its sensitivity
reaches 96%.18
Haemosuccus pancreaticus is an entity diagnosed on clinical,
endoscopic and radiological findings, and a definitive diagnosis
can be established only with angiography. However, haemorrhage
from the papilla of Vater is rarely revealed with endoscopy and the
fistula between the pancreatic duct and aneurysm of the peripan-
creatic vessels are seldom found with angiography and thus up to
52.9% of cases do not achieve definitive diagnosis in some series.19
In such cases, HP was suspected as a result of findings of GI
bleeding and an aneurysm of the peripancreatic vessels in CECT,
and treatment for an aneurysm was then instituted.19 Overall, the
diagnosis of HP requires a high index of suspicion in patients with
pancreatitis and GI bleeding.
There are two therapeutic options for this entity: surgery and
angiographic embolization. Once the haemodynamic situation is
under control, interventional radiographic methods are used for
initial treatment, with immediate good results in 60–100% of
cases (50% in our series).14,20,21 Coil embolization techniques
Table 1 Patient demographics, presenting symptoms, aetiologies
and investigations in the study sample (n = 31)
Mean age, years (range) 34 + 12 (11–55)
Male : female 26:5
Presenting symptoms
Haematemesis, n 10 (8%)
Malena, n 31 (65%)
Pain in the abdomen, n 25 (80%)
Worsening anaemia, n 30 (97%)
Aetiology
Alcoholic chronic pancreatitis, n 12
Tropical chronic pancreatitis, n 16
Alcoholic acute pancreatitis, n 02
Idiopathic pancreatitis, n 1
Transfusion requirements, units (range) 6 (3–12)
Investigations, positive yield
Upper gastrointestinal endoscopy 16/31 (51%)
Ultrasound and Doppler study 12/31 (38%)
Contrast-enhanced computed tomography 28/31 (90%)
Selective angiography 23/26 (88%)
Table 2 Management strategies in the study sample (n = 31)
Angiographic embolization 11/31 (36%)
Attempted 22/26 (84%)
Successful 11/22 (50%)
Surgery 20/31 (64%)
Distal pancreatectomy and splenectomy 11
Central pancreatectomy 2
Intracystic ligation of blood vessel 6
Aneurysmal ligation and bypass graft 1
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provoke a thrombus in the aneurysm, but also obliterate the
artery.22 Ischaemia can develop in the tissue supplied by the artery
if the collateral circulation is not sufficient. Embolization of the
coeliac trunk, the common hepatic artery or the superior mesen-
teric artery is thus contraindicated. Other complications are aneu-
rysm infection and splenic infarction (which occurred in one
patient in our series). Some authors21,23 have reported that patients
are free of recurrent bleeding after exclusive endovascular treat-
ment. Others16 have found recurrence rates to the order of 30%.
Angiographic intervention of a haemorrhage from pseudoaneu-
rysm in HP can be carried out either to stabilize the patient in
order to perform elective surgery or as a definitive treatment.
Endovascular treatment by embolization is effective in most
patients, but there is no consensus concerning the need for asso-
ciated surgery to achieve complete cure. As observed by Lermite
et al.,24 certain authors21,23 have reported that patients are free of
recurrent bleeding after exclusive endovascular treatment. Other
authors16,25 have reported recurrence rates of around 30%. In our
series, selective arterial embolization was attempted in 22 of 26
(84%) patients and was successful in 11 of the 22 (50%); the
remaining patients required surgical management. Failure of
catheter embolization may result from factors such as inability to
isolate the bleeding vessel, incomplete arterial occlusion, or misi-
dentification of the bleeding vessel. If a conservative transarterial
approach is selected in a patient with chronic pancreatitis, the
remaining diseased pancreas adjacent to the previously injured
artery may be the source of re-occurrence of arterial injury and
bleeding.11,19,24 With increasing expertise and the use of super-
selective angiocatheters, therapeutic embolization can serve as a
definitive management strategy.
Surgical treatment is indicated in uncontrolled haemorrhage,
persistent shock and when embolization is not feasible or when
embolization fails (continued or recurrent bleeding), as well as in
patients who have other indications for operative intervention
(pseudocyst, pancreatic abscess, gastric outlet obstruction,
obstructive jaundice or incapacitating pain) and are otherwise
appropriate surgical candidates.26 In our series, 20 of 31 (64%)
patients required surgery to control bleeding after the failure of
arterial embolization in 11 cases and in an emergent setting in
nine. Conservative surgery by ligature of the pancreatic ducts has
been used but results are unsatisfactory because the causal lesion
remains intact. Arterial ligation is also effective, but it does not
avoid the risk of recurrence. Drainage of the pancreatic
pseudocysts associated with arterial ligation is particularly effec-
tive and is associated with fewer complications of infection and
necrosis compared with aggressive surgery. More aggressive
surgery with pancreatic resection enables the treatment of both
the pancreatic and arterial diseases. Surgical procedures in our
series included distal pancreatectomy and splenectomy (n = 11),
central pancreatectomy (n = 2), intracystic ligation of the blood
vessel (n = 6), and aneurysmal ligation and bypass graft (n = 1). In
patients with chronic pancreatitis, pancreaticoduodenectomy
or splenopancreatectomy are preferred by certain authors,10,19 but
(A)
(B)
(C)
Figure 4 Angiography showing (A) opacification of the pancreatic
duct caused by gastroduodenal artery pseudoaneurysm, (B) dye in
the duodenum and (C) post-embolization (with coils)
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the problems of potential perioperative complications and post-
operative pancreatic insufficiency should not be overlooked. Less
radical approaches such as central pancreatectomy and intracystic
ligation of pseudoaneurysm can be performed in place of pancre-
aticoduodenectomy. In six of our patients, we were able to avoid
major resections. Most surgical series have documented success
rates of 70–85%, with mortality rates of 20–25% and rebleeding
rates of 0–5%.4,24,27–29
Conclusions
Upper GI bleeding in a patient with a history of chronic pancreati-
tis could be caused byHP.Diagnosis is based on investigations that
should be performed in all patients, preferably during a period of
active bleeding. These include upper digestive endoscopy and
CECTand selective arteriography of the coeliac trunk and superior
mesenteric artery. Contrast-enhanced computed tomography had
a high positive yield comparable with that of selective angiography
in our series. Therapeutic options consist of selective embolization
and surgery. Endovascular treatment can control unstable haemo-
dynamics and can be sufficient in the some cases. However, in
patientswith persistent unstable haemodynamics, recurrent bleed-
ing or failed embolization, surgery is required.
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